Product Name 產(chǎn)品名稱 | Niacin Extended-Release Tablets 煙酸緩釋片 |
Strength 規(guī)格 | 500 mg 1,000 mg |
Product License | ANDA #214428 |
Indications 適應(yīng)癥 | ? To reduce elevated TC, LDL-C, Apo B and TG, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia. ? To reduce TG in adult patients with severe hypertriglyceridemia. ?降低原發(fā)性高脂血癥和混合性血脂異常患者的TC、LDL-C、Apo B和TG升高，并增加HDL-C。 ?降低患有嚴(yán)重高甘油三酯血癥的成年患者的TG。 |
Approved Date 批準(zhǔn)日期 | 11/22/2021 |
Market Authorization Holder 持有人 | Beijing Sciecure Pharmaceutical Co., Ltd. 北京世橋生物制藥有限公司 |
Manufacture 生產(chǎn)商 | Beijing Sciecure Pharmaceutical Co., Ltd. 北京世橋生物制藥有限公司 |